Study Title: A Study to Evaluate Efficacy and Safety of BMS-986165 in Adults With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) - IM011-132 Sponsor Name: Bristol-Myers Squibb (BMS) Purpose of Study: The purpose of this study is to see if a study medication…
Check out some highlights from another successful World Lupus Day in 2022!
World Lupus Day 2022 is just around the corner! Get ready to help spread awareness about lupus by sharing messages on your social media channels to educate family members and friends about the impact lupus has on millions of lives around the world.
The World Lupus Federation is proud to represent the lupus patient community in a new collaboration to set the bar for what quality care looks like and create a better future for patients living with lupus.
In a recent international survey, the World Lupus Federation found that 87% of the survey respondents living with lupus reported that the disease has impacted one or more major organs or organ systems. Over 6,700 people with lupus participated in the survey from over 100 countries.
Members of the World Lupus Federation are conducting a global online survey to better understand the impact of lupus on the body's organs.
Over one third of survey respondents living with lupus were unable to access the COVID-19 vaccine earlier than the general population
The World Lupus Federation (WLF) is working with lupus organizations around the globe to conduct a survey focusing on the impact of the COVID-19 pandemic on individuals with lupus.
The Addressing Lupus Pillars for Health Advancement (ALPHA) project is a unique global consensus initiative that seeks to identify and prioritize the fundamental barriers or knowledge gaps that will allow providers, researchers and scientists to improve diagnosis, treatment and systems of care for people with lupus.
The World Lupus Federation conducted a global survey on how lupus affects physical function and quality of life.